Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following LungCancer Surgery: a Randomized Controlled Pilot Trial

Department of Cardiothoracic Surgery, Aalborg Universityhospital0 个研究点目标入组 30 人开始时间: 2020年8月14日最近更新: 2020年10月19日

适应症

试验速览

暂无简介。

•1. Patients of 18 years of age or above.
•2. Patients who have undergone pulmonary surgery because of suspicion
•or confirmed pulmonary malignancies.
•3. Patients who are radically treated for pulmonary malignancy
•4. Patients who suffers from chronic pain or unpleasant sensations at the site of scar at least six months after surgery with fully healed surgical wounds.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range 10
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 20

•1. Patients who cannot understand oral and written information.
•2. Patients who were not radically operated.
•3. Patients with other concomitant or other active cancer diseases.
•4. Patients with chronic pain in the chest wall prior to surgery.
•5. Pregnant women or women planning to get pregnant in the study period.
•6. Patients with autoimmune neuromuscular diseases, sclerosis, peripheral
•neuromuscular disturbances and general muscle weakness or atrophy.
•7. Patients with intolerance or allergy to BOTOX®.
•8. Patients who are at present treated with Onabotulinum toxin A or similar neuromuscular blocking drug or have received such in the past year.

发起方

Department of Cardiothoracic Surgery, Aalborg Universityhospital